TTAB Extensions of Time to Oppose 88237412
USPTO Extensions of Time to Oppose proceeding 88237412, filed 2022-07-27. Status: Terminated.
Proceeding Facts
| Proceeding Number | 88237412 |
|---|---|
| Type | Extensions of Time to Oppose |
| Status | Terminated |
| Filing Date | 2022-07-27 |
| Last Activity | 2022-08-04 |
| Days Active | 1388 |
Parties
- CytomX Therapeutics, Inc. — Defendant
- Iovance Biotherapeutics, Inc. — Plaintiff
- NOVARTIS CORPORATION — Plaintiff
Plaintiff Marks
- No plaintiffs on record.
Defendant Marks
- IOVANDA — CytomX Therapeutics, Inc.
Recent Documents
- 2022-08-04: EXT GRANTED — Extensions
- 2022-08-04: FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE — Extensions
- 2022-07-27: EXT GRANTED — Extensions
- 2022-07-27: FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE — Extensions